Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia is Associated with Multiple Clinical Conditions

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: V. Margelidon-Cozzolino reports non-financial support for travel to medical meetings from Actelion and Vitalaire outside the submitted work.

Conflict of interest: V. Cottin reports advisory board and lecture fees, and travel support from Actelion; grants, consultancy and lecture fees, and travel support from Boehringer Ingelheim and Roche; advisory board and data safety monitoring board (DSMB) fees from Bayer/MSD and Galapagos; advisory board and lecture fees from Novartis; lecture fees from Sanofi; DSMB and steering committee fees from Promedior; and DSMB fees from Celgene and Galecto, all outside the submitted work.

Conflict of interest: Dr. DUPUIS-GIROD has nothing to disclose.

Conflict of interest: J. Traclet reports travel to medical meetings supported by Roche, Boehringer Ingelheim, CSL Behring and Actelion, and lecture fees from Actelion, outside the submitted work.

Conflict of interest: K. Ahmad reports lecture fees and invitations to medical meetings from Actelion and from Roche, and invitations to medical meetings from Boehringer Ingelheim, outside the submitted work.

Conflict of interest: J.F. Mornex reports consultancy fees from LFB Biomedicaments and CSL Behring, lecture fees and travel support from Actelion, consultancy fees from Adene, travel support from Agiradom and Amgen, travel support and lecture fees from Boehringer Ingelheim and Roche, and travel support from Novartis, Pfizer and Vitalaire, outside the submitted work.

Conflict of interest: S. Turquier reports lecture fees and a congress invitation from Actelion, and a congress invitation from Vitalaire, outside the submitted work.